SEL-037

SEL-037 · Selecta Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEL-037, covering 2022-02-14 to 2022-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid [Phase 2]

See pricing